Last reviewed · How we verify
NCT05836675
Quality of Life and Sexual Life in Hemodialysis Patients: Effects of an Intradialytic Exercise Program
NA trial testing Intradialytic exercise in Chronic Kidney Diseases in 37 participants. Completed in 19 June 2025.
30 April 2024
Quick facts
| Lead sponsor | Universidad Autónoma de Yucatán |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 37 |
| Start date | 8 August 2023 |
| Primary completion | 30 April 2024 |
| Estimated completion | 19 June 2025 |
| Sites | 2 locations across Mexico |
Drugs / interventions tested
- Intradialytic exercise
Conditions studied
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
- Sexual Dysfunction — all drugs for Sexual Dysfunction →
Sponsor
Universidad Autónoma de Yucatán
Who can join
Adults 18 to 70, any sex, with Chronic Kidney Diseases or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to investigate whether an intradialytic exercise program can improve the quality of life, sexual function, and sexual satisfaction in patients undergoing hemodialysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05836675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intradialytic exercise
Trials testing the same drug.
- NCT05382468 — Effectiveness of Intradialytic Exercise on Reduction in Fatigue and Muscle Cramps · NA · completed
- NCT05246956 — Investigation of the Effect of Intradialytic Exercise on Functional Capacity,Quality of Life in Hemodialysis Patients · NA · unknown
- NCT03353844 — The Effects of Intradialytic Exercise in Hemodiafiltration Patients · NA · completed
Other recruiting trials for Chronic Kidney Diseases
Currently open trials in the same condition.
- NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
- NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
- NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
- NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
- NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting
Other Universidad Autónoma de Yucatán trials
Trials by the same sponsor.
- NCT05452499 — Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05836675 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autónoma de Yucatán
- Last refreshed: 26 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05836675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing